Poster presentation highlighted promising pharmacology and behavioral results on lead candidate, TN-001, in preclinical studies. TN-001 is under development for both major depressive disorder (MDD) ...
Synbio International Inc. (OTC: SYIN) ("Synbio" or the "Company"), a medical technology company focused on clinically ...
New research links inflammation to mental health symptoms. Personalized care using brain and immune data could improve ...
DENVER, CO / / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous ...
The latest fair value estimate for Myriad Genetics has shifted only slightly, now at US$8.32 compared with US$8.52 before, ...
Valerie Zeko emerged from 28 years of debilitating depression after participating in a groundbreaking trial at Stanford, ...
Research shows that vagus nerve stimulation can provide long-lasting benefits for patients who do not respond to conventional treatments Around 20% of adults in the United States will experience major ...
DENVER, CO / ACCESS Newswire / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central n ...
Morning Overview on MSN
Brain scans may soon match depression patients to the right treatment
For decades, treating major depression has involved a frustrating cycle of trial and error, with patients cycling through ...
When it comes to serious mental illness, family caregivers are crucial partners. But often, they must fend for themselves. A ...
A U.S. study shows that sleeping longer on weekends is linked to fewer daily depression symptoms in teens and young adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback